166 related articles for article (PubMed ID: 20402765)
1. Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1).
Eigenbrot C; Ganesan R; Kirchhofer D
FEBS J; 2010 May; 277(10):2215-22. PubMed ID: 20402765
[TBL] [Abstract][Full Text] [Related]
2. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
Hashimoto T; Kato M; Shimomura T; Kitamura N
FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
[TBL] [Abstract][Full Text] [Related]
4. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H
FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492
[TBL] [Abstract][Full Text] [Related]
5. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
[TBL] [Abstract][Full Text] [Related]
7. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
8. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein.
Kawaguchi M; Orikawa H; Baba T; Fukushima T; Kataoka H
FEBS J; 2009 Jul; 276(13):3481-90. PubMed ID: 19456860
[TBL] [Abstract][Full Text] [Related]
10. Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis.
Marchand-Adam S; Fabre A; Mailleux AA; Marchal J; Quesnel C; Kataoka H; Aubier M; Dehoux M; Soler P; Crestani B
Am J Respir Crit Care Med; 2006 Jul; 174(1):58-66. PubMed ID: 16574935
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human.
Itoh H; Kataoka H; Hamasuna R; Kitamura N; Koono M
Biochem Biophys Res Commun; 1999 Feb; 255(3):740-8. PubMed ID: 10049781
[TBL] [Abstract][Full Text] [Related]
13. Role of the stem domain of matriptase in the interaction with its physiological inhibitor, hepatocyte growth factor activator inhibitor type I.
Kojima K; Tsuzuki S; Fushiki T; Inouye K
J Biochem; 2009 Jun; 145(6):783-90. PubMed ID: 19276202
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor activator (HGFA).
Kataoka H
FEBS J; 2010 May; 277(10):2207. PubMed ID: 20402767
[No Abstract] [Full Text] [Related]
15. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
[TBL] [Abstract][Full Text] [Related]
16. Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1).
Kataoka H; Itoh H; Hamasuna R; Meng JY; Koono M
Hum Cell; 2001 Mar; 14(1):83-93. PubMed ID: 11436357
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.
Kataoka H; Shimomura T; Kawaguchi T; Hamasuna R; Itoh H; Kitamura N; Miyazawa K; Koono M
J Biol Chem; 2000 Dec; 275(51):40453-62. PubMed ID: 11013244
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo.
Kataoka H; Kawaguchi M
FEBS J; 2010 May; 277(10):2230-7. PubMed ID: 20402763
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
Murthy HM; Judge K; DeLucas L; Padmanabhan R
J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
